These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 18226584)

  • 1. Apical membrane antigen 1: a malaria vaccine candidate in review.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
    Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
    Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caught in action: mechanistic insights into antibody-mediated inhibition of Plasmodium merozoite invasion.
    Treeck M; Tamborrini M; Daubenberger CA; Gilberger TW; Voss TS
    Trends Parasitol; 2009 Nov; 25(11):494-7. PubMed ID: 19734093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.
    Healer J; Murphy V; Hodder AN; Masciantonio R; Gemmill AW; Anders RF; Cowman AF; Batchelor A
    Mol Microbiol; 2004 Apr; 52(1):159-68. PubMed ID: 15049818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
    Polley SD; Mwangi T; Kocken CH; Thomas AW; Dutta S; Lanar DE; Remarque E; Ross A; Williams TN; Mwambingu G; Lowe B; Conway DJ; Marsh K
    Vaccine; 2004 Dec; 23(5):718-28. PubMed ID: 15542195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
    Henderson KA; Streltsov VA; Coley AM; Dolezal O; Hudson PJ; Batchelor AH; Gupta A; Bai T; Murphy VJ; Anders RF; Foley M; Nuttall SD
    Structure; 2007 Nov; 15(11):1452-66. PubMed ID: 17997971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
    Bruder JT; Stefaniak ME; Patterson NB; Chen P; Konovalova S; Limbach K; Campo JJ; Ettyreddy D; Li S; Dubovsky F; Richie TL; King CR; Long CA; Doolan DL
    Vaccine; 2010 Apr; 28(18):3201-10. PubMed ID: 20188680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of Plasmodium falciparum apical membrane antigen 1 utilizing interspecies domains.
    Healer J; Triglia T; Hodder AN; Gemmill AW; Cowman AF
    Infect Immun; 2005 Apr; 73(4):2444-51. PubMed ID: 15784590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, crystallization and preliminary structural analysis of the ectoplasmic region of apical membrane antigen 1 from Plasmodium vivax, a malaria-vaccine candidate.
    Vulliez-Le Normand B; Pizarro JC; Chesne-Seck ML; Kocken CH; Faber B; Thomas AW; Bentley GA
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2040-3. PubMed ID: 15502321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1.
    Feng ZP; Keizer DW; Stevenson RA; Yao S; Babon JJ; Murphy VJ; Anders RF; Norton RS
    J Mol Biol; 2005 Jul; 350(4):641-56. PubMed ID: 15964019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
    Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
    J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.
    Lalitha PV; Ware LA; Barbosa A; Dutta S; Moch JK; Haynes JD; Fileta BB; White CE; Lanar DE
    Infect Immun; 2004 Aug; 72(8):4464-70. PubMed ID: 15271904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites.
    Cao J; Kaneko O; Thongkukiatkul A; Tachibana M; Otsuki H; Gao Q; Tsuboi T; Torii M
    Parasitol Int; 2009 Mar; 58(1):29-35. PubMed ID: 18952195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide.
    Tonkin ML; Roques M; Lamarque MH; Pugnière M; Douguet D; Crawford J; Lebrun M; Boulanger MJ
    Science; 2011 Jul; 333(6041):463-7. PubMed ID: 21778402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
    Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
    PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
    Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
    PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.